Skip to main content

Table 2 Characteristics of the stimulation cycle

From: Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study

Variables

PPOS group (n = 120)

Antagonist group (n = 120)

P-value

Starting dose of FSH (IU)

225.0 (225.0-225.0)

225.0 (225.0-225.0)

0.134

Total dosage of FSH (IU)

1800.0 (1575.0-2025.0)

1800.0 (1575.0-2212.5)

0.010

Duration of stimulation (days)

8.0 (7.0-8.8)

8.0 (7.0–9.0)

0.053

Serum estradiol level on trigger day (pg/ml)

1870.5 (912.7-2940.1)

1061.3 (592.0-2614.1)

0.007

Serum LH level on trigger day (IU/l)

4.3 (2.7–5.9)

2.4 (1.6–3.6)

0.000

Serum progesterone level on trigger day (ng/ml)

0.9 (0.6–1.2)

0.8 (0.6–1.2)

0.588

Premature ovulation (%)

0.8 (1/120)

0.8 (1/120)

1

No. of retrieved oocytes (n)

6.0 (3.0–10.0)

5.0 (3.0–10.0)

0.914

No. of mature occytes (n)

4.5 (2.0–8.0)

4.0 (3.0–9.0)

0.980

No. of oocytes fertilized (n)

3.0 (2.0–7.0)

3.0 (2.0–6.0)

0.728

Fertilization rate (%)

94.4 (75.0-100)

92.9 (75.0-100)

0.746

Cleavage rate (%)

100 (100–100)

100 (100–100)

0.648

No. of blastocysts formation (n)

1.5 (0–3.0)

1.0 (0–3.0)

0.422

Blastocysts formation rate (%)

59.4 (33.3–100)

50.0 (33.3–80)

0.299

Total No. of euploid blastocysts

93

97

 

No. of euploid blastocysts (n)

0 (0–1.0)

0 (0–1.0)

0.995

Euploid blastocysts rate per injected oocyte (%)

12.5 (0–25.0)

16.0 (0-27.7)

0.477

Euploid blastocysts rate per woman (%)

33.3 (0-66.7)

50.0 (0-66.7)

0.459

No. of cycles with no blastocyst for biopsy (%)

27.5 (33/120)

30.0 (36/120)

0.669

No. of cycles with no euploid blastocysts for transfer (%)

52.5 (63/120)

55.0 (66/120)

0.698